The Manufacturers Life Insurance Company lifted its position in Tilray Inc (NASDAQ:TLRY – Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 715,672 shares of the company’s stock after acquiring an additional 33,194 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Tilray were worth $1,260,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also modified their holdings of TLRY. Bank of Montreal Can increased its holdings in Tilray by 19.6% during the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after purchasing an additional 355,778 shares in the last quarter. J.W. Cole Advisors Inc. increased its holdings in Tilray by 1,077.2% during the second quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock worth $284,000 after buying an additional 156,524 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Tilray by 80.8% during the 2nd quarter. SG Americas Securities LLC now owns 345,240 shares of the company’s stock worth $573,000 after purchasing an additional 154,334 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Tilray by 3.5% in the first quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock valued at $8,707,000 after buying an additional 117,891 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in Tilray by 8.1% in the 2nd quarter. TD Asset Management Inc now owns 1,373,045 shares of the company’s stock valued at $2,278,000 after purchasing an additional 103,207 shares during the period. Hedge funds and other institutional investors own 9.35% of the company’s stock.
Tilray Stock Performance
Tilray stock opened at $1.26 on Thursday. Tilray Inc has a 1-year low of $1.22 and a 1-year high of $2.97. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $1.14 billion, a PE ratio of -4.67 and a beta of 2.09. The firm’s 50 day simple moving average is $1.50 and its 200 day simple moving average is $1.68.
Analyst Ratings Changes
Separately, Roth Mkm reduced their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.
Read Our Latest Research Report on Tilray
Insider Activity
In other Tilray news, CFO Carl A. Merton acquired 26,000 shares of the business’s stock in a transaction dated Friday, November 15th. The shares were purchased at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the purchase, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. The trade was a ? increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.87% of the company’s stock.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
- Five stocks we like better than Tilray
- What is the S&P 500 and How It is Distinct from Other Indexes
- The Great CPU Race: AMD and Intel Battle for Dominance
- Business Services Stocks Investing
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.